|Trial status||Trial open for recruitment|
Prospective observational study
|Phase||Trial phase 4|
|Sponsor||BMS - Bristol Myers Squibb int.|
|Inclusion criteria||Complete resection|
The new Institut Jules Bordet, a building for the practice of medical excellence now and in the future. Meeting at the end of November 2021 on the ULB campus in Anderlecht.